Beyond surgical radicality in intramedullary spinal cord metastases: neurological function and systemic disease burden drive patient outcomes
- PMID: 40587076
- PMCID: PMC12367927
- DOI: 10.1007/s11060-025-05119-5
Beyond surgical radicality in intramedullary spinal cord metastases: neurological function and systemic disease burden drive patient outcomes
Abstract
Purpose: Intramedullary spinal cord metastases (ISCM) are rare, clinically challenging lesions with limited evidence-based guidance. Optimal surgical management remains controversial, particularly regarding the ideal extent of resection (EOR) and associated prognostic factors. This study systematically evaluates perioperative outcomes, neurological function, and short-term survival according to biopsy-only, subtotal, or gross total resection (GTR) approaches.
Methods: This retrospective single-center study included 16 patients treated surgically for histologically confirmed ISCM between 2015 and 2024. Patients were stratified by surgical extent (biopsy, subtotal, or total resection). Outcomes included perioperative complications, neurological function, and 90-day survival. A literature review of surgical ISCM series (≥ 5 cases) was also performed.
Results: Sixteen patients with a median age of 59 years (56% male) were included. Thoracic lesions predominated (56%). Surgical complications were seen in 19% of the cases, however no irreversible neurological injury and no intraoperative mortality or transfusion occured. Early mortality was lowest following GTR (13%) compared to subtotal (60%) or biopsy-only (33%) approaches (p = 0.015). However, multivariable regression showed that EOR alone was not independently predictive of short-term survival (p = 0.834), indicating patient selection bias. Neurological function remained stable or improved in all of cases, irrespective of resection extent.
Conclusion: Surgical management of ISCM can be performed safely with minimal neurological morbidity, achieving symptom stabilization or improvement. Although GTR was associated with favorable short-term survival, systemic disease burden and postoperative neurological function are stronger prognostic factors. Therefore, surgical decisions should prioritize functional preservation and patient selection based on disease extent and overall health.
Keywords: Extent of resection; ISCM; Intramedullary metastases; Neurosurgical oncology; Spinal metastases.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate/publish: This retrospective analysis of ISCM patients was approved by the local Ethics Committee in accordance with the Declaration of Helsinki. Explicit consent to participate from each patient was not available due to the retrospective study design and many patients of the cohort had already deceased. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
Effect of surgical resection extent on neurological prognosis of adult intradural spinal teratomas.Acta Neurochir (Wien). 2024 Oct 19;166(1):418. doi: 10.1007/s00701-024-06314-5. Acta Neurochir (Wien). 2024. PMID: 39425802
-
Surgical outcomes and natural history of intramedullary spinal cord cavernous malformations: a single-center series and meta-analysis of individual patient data: Clinic article.J Neurosurg Spine. 2014 Oct;21(4):662-76. doi: 10.3171/2014.6.SPINE13949. Epub 2014 Jul 25. J Neurosurg Spine. 2014. PMID: 25062285
-
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22. Clin Orthop Relat Res. 2024. PMID: 38517402
-
Functional nerve root tumors have worse resection rates: Outcome predictors for gross total resection in non-syndromic spinal schwannomas.Clin Neurol Neurosurg. 2025 Sep;256:109021. doi: 10.1016/j.clineuro.2025.109021. Epub 2025 Jun 23. Clin Neurol Neurosurg. 2025. PMID: 40582179
-
A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420. Health Technol Assess. 2013. PMID: 24070110 Free PMC article.
References
-
- Tobin MK, Geraghty JR, Engelhard HH, Linninger AA, Mehta AI (2015) Intramedullary spinal cord tumors: a review of current and future treatment strategies. Neurosurg Focus 39:E14. 10.3171/2015.5.FOCUS15158 - PubMed
-
- Balmaceda C (2000) Chemotherapy for intramedullary spinal cord tumors. J Neurooncol 47:293–307. 10.1023/a:1006499313482 - PubMed
-
- Sung WS, Sung MJ, Chan JH, Manion B, Song J, Dubey A, Erasmus A, Hunn A (2013) Intramedullary spinal cord metastases: a 20-year institutional experience with a comprehensive literature review. World Neurosurg 79:576–584. 10.1016/j.wneu.2012.04.005 - PubMed
-
- Isla A, Paz JM, Sansivirini F, Zamora P, Garcia Grande A, Fernandez A (2000) Intramedullary spinal cord metastasis. A case report. J Neurosurg Sci 44:99–101 - PubMed
-
- Manzano G, Green BA, Vanni S, Levi AD (2008) Contemporary management of adult intramedullary spinal tumors-pathology and neurological outcomes related to surgical resection. Spinal Cord 46:540–546. 10.1038/sc.2008.51 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources